Alfred Welle

Doctor of Medicine,  Charité - Universitätsmedizin Berlin 

Location: India

Consulting Services

Grant Submission Research Consulting Legal Support Data Science-Bioinformatics Admin and Customer Support

Areas Of Interest

Logistic Regression Arterial Lines DNA Probes, HLA-DR Pre-Par Hereditary Elliptocytosis Diets, Low-Salt Cytidine 5 Monophosphosialate Synthase E-Mulsin Naked DNA Vaccines Ethics Committees, Clinical Paralysis Virus, Fowl Drugs, Sympatholytic Alpha-Lipon Stada Peptide Chain Termination, Translational Prestyloid Compartment of the Parapharyngeal Space Hemifacial Atrophy, Progressive Cyanoacrylates Feline Leukemias Olivopontocerebellar Atrophies, Nonfamilial Anorectal Atresia Epithelioid Hemangioendothelioma Hydrochloride Anhydrous, Ciprofloxacin Muscles, Abdominal Oblique Cryptococcal Meningitides Mechanical Phenomena Bionators FISH Technic Trees, Locust Count, Sperm Suntan Area Dentata Antephase Checkpoint Cycles, Cell Division Glycosyltransferases Colombian White-Faced Capuchin X-ray Repair Cross-Complementing Protein 5 Herbicide Resistance Ginsengs, Alaskan C EBP beta Sequestering Agents

Professional Narrative

Dr. Alfred Welle was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Welle has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Assistant Professor, Harvard Med 2019
Executive Director, Harvard Med 1995

Education

Bachelor of science in nursing, Baylor College 2014
Doctor of osteopathic medicine, Harvard Medical School 1994

Referees

Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02